Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 17 Mar 2026 for Amphastar Pharmaceuticals, Inc., €16k. Read the official filing
Filing timeline
BuySaleYakob Liawatidewi
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Yakob Liawatidewi: trading record in brief
Yakob Liawatidewi discloses dealings in Amphastar Pharmaceuticals, Inc. to SEC (Form 4). The record holds 35 filings, for trades running from 11 May 2021 to 15 March 2026.
Sales make up the whole of the open-market record (2 sales, €1.5M). Besides market trades, the filings include 22 share grants and 11 option exercises.
The record was last updated on 17 March 2026 with a share grant (€16k) in Amphastar Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Yakob Liawatidewi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations35 total
1,033 shares@ US$18.180.6% of flowCommon StockSEC:0001743927-26-000010:0
35,450 shares0Common StockSEC:0001743927-26-000008:0
1,144 shares@ US$19.340.0016% mcap0.7% of flowCommon StockSEC:0001743927-26-000006:0
965 shares@ US$19.960.6% of flowCommon StockSEC:0001743927-26-000003:0
1,031 shares@ US$26.660.9% of flowCommon StockSEC:0001415889-25-008500:0
20,837 shares0Common StockSEC:0001415889-25-007798:0
1,141 shares@ US$28.321.1% of flowCommon StockSEC:0001415889-25-007503:0
963 shares@ US$27.620.9% of flowCommon StockSEC:0001415889-25-007198:0
5,214 shares@ US$13.032.2% of flowCommon StockSEC:0001415889-24-026480:0
272 shares@ US$42.220.4% of flowCommon StockSEC:0001415889-24-015637:0
1,027 shares@ US$43.051.4% of flowCommon StockSEC:0001415889-24-008604:0
1,221 shares@ US$46.311.8% of flowCommon StockSEC:0001415889-24-007362:0
10,754 shares0Common StockSEC:0001415889-24-007091:0
3,319 shares@ US$16.961.8% of flowCommon StockSEC:0001104659-23-096618:0
5,497 shares@ US$20.233.6% of flowCommon StockSEC:0001104659-23-096618:1
20,000 shares@ US$13.038.5% of flowCommon StockSEC:0001104659-23-096618:2
28,816 shares@ US$53.1350.0% of flowCommon StockSEC:0001104659-23-096618:3
378 shares@ US$46.700.6% of flowCommon StockSEC:0001104659-23-068617:0
11,494 shares@ US$20.237.4% of flowCommon StockSEC:0001104659-23-045715:0
5,000 shares@ US$20.233.3% of flowCommon StockSEC:0001104659-23-044692:0
1,620 shares@ US$37.602.0% of flowCommon StockSEC:0001104659-23-034577:0
1,851 shares@ US$36.842.2% of flowCommon StockSEC:0001104659-23-034073:0
12,752 shares0Common StockSEC:0001104659-23-030097:0
5,000 shares@ US$19.793.4% of flowCommon StockSEC:0001104659-22-088691:0
10,837 shares@ US$19.797.6% of flowCommon StockSEC:0001104659-22-080589:0
25 of 35 declarations
